Evidence map›Paper›PMID 32537407›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Targeted Repair of Vascular Injury by Adipose-Derived Stem Cells Modified with P-Selectin Binding Peptide.

Hongyu Yan, Xingyan Mi, Adam C Midgley, Xinchen Du, Ziqi Huang, Tingting Wei, Ruihua Liu, Tengzhi Ma, Dengke Zhi, Dashuai Zhu and 8 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Versatile Design of NO-Generating Proteolipid Nanovesicles for Alleviating Vascular Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  9. Article
  10. Article
  11. Functionalization ofBioactive materials · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Hongyu YanKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Xingyan MiKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Adam C MidgleyKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Xinchen DuKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Ziqi HuangKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Tingting WeiKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Ruihua LiuKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Tengzhi MaKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Dengke ZhiKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Dashuai ZhuSchool of Medicine Nankai University Tianjin 300071 China.
Ting WangUrban Transport Emission Control Research Centre College of Environmental Science and Engineering Nankai University Tianjin 300071 China.
Guowei FengDepartment of Genitourinary Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin 300060 China.
Ying ZhaoDonation Services Tianjin First Central Hospital Tianjin 300192 China.
Weiye ZhangDonation Services Tianjin First Central Hospital Tianjin 300192 China.
Ju HeDepartment of Vascular Surgery Tianjin First Central Hospital Tianjin 300192 China.
Meifeng ZhuKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.
Deling KongKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.ORCID https://orcid.org/0000-0002-2961-9267
Kai WangKey Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China.ORCID https://orcid.org/0000-0003-3317-3509
Nankai University · CNTianjin First Center Hospital · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Percutaneous coronary intervention for coronary artery disease treatment often results in pathological vascular injury, characterized by P-selectin overexpression. Adipose-derived stem cells (ADSCs) therapeutic efficacy remains elusive due to poor ADSCs targeting and retention in injured vessels. Here, conjugated P-selectin binding peptide (PBP) to polyethylene glycol-conjugated phospholipid derivative (DMPE-PEG) linkers (DMPE-PEG-PBP; DPP) are used to facilitate the modification of PBP onto ADSCs cell surfaces via hydrophobic interactions between DMPE-PEG and the phospholipid bilayer. DPP modification neither has influence on ADSCs proliferation nor apoptosis/paracrine factor gene expression. A total of 5 × 10

Indexed as

adipose‐derived stem cellsliving cell‐surface modificationPEG lipidP‐selectinvascular injury

Identifiers

PMID32537407
PMCPMC7284211
OpenAlexW3017778508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.